Pricing Sign in

Role
Country
Date of registration
Address

Made In Tracker

Made In Tracker EasyUDI

Legal

Privacy Policy Legal Notice

About

About FAQ Contact

Our data is continuously updated and sourced from EUDAMED, the European database for medical devices and in vitro diagnostics.

Subscribe to our monthly newsletter:

By subscribing, you accept the General Personal Data Protection Policy.

Organization name
UDI-DI code
Reference / catalog number

1140016_BSX — IVDD — General IVDD by BIOSYNEX Swiss SA

MD Atlas
BIOSYNEX Swiss SA

EUDAMED last updated this device on May 6, 2026

1140016_BSX

B-03532670100461

On the marketIVDD — General

Applicable legislation: IVDD [Directive 98/79/EC on in vitro diagnostic medical devices]
Organization name: BIOSYNEX Swiss SA
UDI-DI code: 03532670100461
Reference / catalog number: 1140016_BSX

Sign in to open the EUDAMED record

The link to the official EUDAMED page is reserved for signed-in users. Create a free account to continue.

Email

Password

No account yet?

Manufacturer information

Organization name: BIOSYNEX Swiss SA
SRN: CH-MF-000024717
Manufacturer status: Active

Critical warnings

1 warning recorded — scroll inside the panel to see all entries.

CW010
EUDAMED did not publish a description for this code.

Market distribution

Primary placement in France; available across 1 country total.

Country	On market since	Until
FrancePrimary placement		Still on market

Device identification

Trade name: not provided
UDI-DI code: 03532670100461
Basic UDI-DI: B-03532670100461
Reference / catalog number: 1140016_BSX
Issuing entity: GS1

Classification

Risk category: IVDD — General
Applicable legislation: IVDD [Directive 98/79/EC on in vitro diagnostic medical devices]
Status: On the market

Device details

Quantity: 1
Additional product description: Rapid multi‑drug test for the qualitative detection of amphetamines (AMP), buprenorphine (BUP), barbiturates (BAR), benzodiazepines (BZO), cocaine (COC), methadone (MTD), methamphetamine (MET), ecstasy (MDMA), morphine (MOP), cannabis (THC), and tricyclic antidepressants (TCA) in urine. Warning: This DRUGCHECK+ 11 BSX test as well as all other tests in the BSX range are dedicated to be read and interpreted by the BSX READER supplied separately (ref. 5060029).
Additional information URL: https://www.biosynex.com/
Clinical sizes: No clinical sizes registered for this device.

EMDN nomenclature code(s)

W0102160511MULTIPLE DRUGS OF ABUSE/TOXICOLOGY RT & POC

Compliance flags

Safety

Sterile

Single use

Direct marking

Regulatory

Sterilization

Lifecycle

New device

UDI-PI traceability

Batch number
Expiration date
Manufacturing date
Serial number
Software identification

Related devices

859263B-03532678592633On the market 859261B-03532678592619On the market 859257B-03532678592572On the market 859385B-03532678593852On the market 859258B-03532678592589On the market

Certificates

No certificates registered for this manufacturer.

No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.